Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of

Biomolecules, Free Full-Text

IJMS, Free Full-Text

Synergy between plasminogen activator inhibitor-1, α-synuclein, and neuroinflammation in Parkinson's disease - ScienceDirect

Model for TGF-β1-induced PAI-1 expression. TGF-β1 activates two

Aging, Plasminogen Activator Inhibitor 1, Brain Cell Senescence, and Alzheimer's Disease

Increased expression of plasminogen activator inhibitor-1 (PAI-1) is associated with depression and depressive phenotype in C57Bl/6J mice

Synergy between plasminogen activator inhibitor-1, α-synuclein, and neuroinflammation in Parkinson's disease - ScienceDirect

Therapeutics targeting the fibrinolytic system

Plasminogen activator inhibitor-1 in cancer research - ScienceDirect

Pharmacological inhibition of plasminogen activator inhibitor-1 prevents memory deficits and reduces neuropathology in APP/PS1 mice

Plasminogen Activator Inhibitor-1 Promotes the Recruitment and Polarization of Macrophages in Cancer - ScienceDirect

Plasminogen Activator Inhibitor-1 and Oncogenesis in the Liver Disease

Figure 4 from Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of Senescence.

Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome